Literature DB >> 3435570

Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis.

M J Rowley1, D J Williamson, I R Mackay.   

Abstract

Synovial fluid samples from 36 patients with rheumatoid arthritis (RA) and 31 patients with other articular diseases (OAD) were examined for the presence of antibodies to denatured or native human type II collagen. Levels of IgG antibodies to denatured or native human type II collagen, rheumatoid factor, immunoglobulins, and total proteins were assessed in paired samples of serum and synovial fluid from 21 patients with RA and from 14 patients with OAD. Solid-phase radioimmunoassay showed that levels of antibodies to denatured collagen in synovial fluid were significantly higher in RA patients than in OAD patients (median 3,270, range 44-16,816 versus median 919, range 119-5,814; P less than 0.001). These antibody levels were higher in synovial fluid than in the serum of RA patients, but not in patients with OAD. Paired serum and synovial fluid samples showed no correlation between the level of antibodies to denatured collagen and levels of either IgG, IgA, IgM, or rheumatoid factor. Synovial fluid antibodies to native collagen were higher in RA patients. Antibodies to collagen may be synthesized preferentially in synovial tissues and, hence, participate in the perpetuation of RA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435570     DOI: 10.1002/art.1780301215

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

3.  Comparison of microheterogeneity of alpha-1-acid-glycoprotein in serum and synovial fluid from rheumatoid arthritis patients.

Authors:  J K Lacki; K Klama; W Samborski; S H Mackiewicz; W Muller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

4.  Pattern of humoral reactivity to type II collagen in rheumatoid arthritis.

Authors:  M C Boissier; G Chiocchia; B Texier; C Fournier
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 5.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

6.  Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

Authors:  M Londei; C M Savill; A Verhoef; F Brennan; Z A Leech; V Duance; R N Maini; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Associations between HLA and antibodies to collagen in rheumatoid arthritis.

Authors:  M J Rowley; B Tait; T Doran; P Emery; I R Mackay
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

8.  Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study.

Authors:  A Stockman; M J Rowley; P Emery; K D Muirden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

9.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis.

Authors:  M Field; C Chu; M Feldmann; R N Maini
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.